ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2021)
Historic Change in Accured Expenses for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$37693.0.
- ENDRA Life Sciences' Change in Accured Expenses rose 9035.55% to -$37693.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $491104.0, marking a year-over-year increase of 15881.56%. This contributed to the annual value of -$198867.0 for FY2024, which is 7581.45% up from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Change in Accured Expenses is -$37693.0, which was up 9035.55% from -$65736.0 recorded in Q3 2021.
- ENDRA Life Sciences' 5-year Change in Accured Expenses high stood at $818065.0 for Q2 2021, and its period low was -$390823.0 during Q4 2020.
- Over the past 5 years, ENDRA Life Sciences' median Change in Accured Expenses value was -$51714.5 (recorded in 2021), while the average stood at $53546.0.
- Over the last 5 years, ENDRA Life Sciences' Change in Accured Expenses had its largest YoY gain of 66583.37% in 2019, and its largest YoY loss of 126308.32% in 2019.
- ENDRA Life Sciences' Change in Accured Expenses (Quarter) stood at $536173.0 in 2017, then plummeted by 117.49% to -$93756.0 in 2018, then soared by 665.83% to $530503.0 in 2019, then plummeted by 173.67% to -$390823.0 in 2020, then skyrocketed by 90.36% to -$37693.0 in 2021.
- Its last three reported values are -$37693.0 in Q4 2021, -$65736.0 for Q3 2021, and $818065.0 during Q2 2021.